Patients with active disease who received treatment
| Disease activity | Genotype | ALT (IU/mL) | Viral load (IU/mL) | Fibroscan result (kPa) | Liver biopsy (METAVIR) | Treatment |
|---|---|---|---|---|---|---|
| eAg +ve active CHB | C | 81 | 1.7×108 | 4.2 | A1 F1 | Pegasys IFN postpartum |
| eAg +ve active CHB | C | 119 | 1.7×108 | 16.3 | A3 F4 | Tenofovir postpartum |
| eAg –ve active CHB | C | 203 | 3.7×105 | 5.1 | A2 F1 | Tenofovir postpartum |
| eAg –ve active CHB | E | 122 | 1.9×104 | 9.1 | A1 F3 | Tenofovir postpartum |
CHB, ; eAg, e antigen; IFN, interferon.